J4 ›› 2012, Vol. 11 ›› Issue (12): 58-62.
Previous Articles Next Articles
Received:
Revised:
Online:
Published:
Abstract:
Objective: To investigate the clinical distribution and drug resistance of four kinds of Gram-negative bacillus in Affiliated Hospital of Dali University and provide basis for clinical medicine. Methods: VITET-2 compact automated microbial analyzer was applied for bacterial identification, K-B disk diffusion method were used for drug sensitive test. Results: The drug resistance rates of four kinds of bacilli to penicillins, sulfonamides, quinolones and amoxicillin amoxicillin/clavulanic acid, gentamicin, cephalosporins, aztreonam, resistance rates were 75%、75%、20%、70%、55%、50%、13%, respectively. P. aeruginosa was more sensitive to ceftazidime (7.22%) and cefepime (11.86%). E. coli and K. pneurmoniae were sensitive to both carbapenem and cefoperazone/sulbactam, while P. aeruginosa were resistant to both carbapenem and cefoperazone/sulbactam, A. baumanii was sensitive to imipenem and cefoperazone/sulbactam. E. coli and P. aeruginosa were sensitive to amikacin, K. pneurmoniae was sensitive to piperacillin / tazobactam, but was resistance to others (>14%). Conclusion: There were high drug resistences of 4 Gram-negative bacillus in affiliated hospital of Dali University, hospital should be strengthened infection control, drug monitoring and clinical use of antimicrobial drugs, reducing the emergence of resistant or multi-drug-resistant strains.
Key words: G-negative bacillus, E. coil, K. pneurmoniae, A. baumanii, P. aeruginosa, drug-resistance
CLC Number:
R378.2+1
LI Xiao-Juan, ZHANG Qun-Zhi. Clinical Distribution and Drug Resistance of Four Kinds of Gram-negative Bacillus in Affiliated Hospital of Dali University[J]. J4, 2012, 11(12): 58-62.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://journal15.magtechjournal.com/Jwk_dlxyzk/EN/
http://journal15.magtechjournal.com/Jwk_dlxyzk/EN/Y2012/V11/I12/58
〔1〕黄娥,范文,段六生.荆州市医院感染大肠埃希菌的耐药 性分析〔J〕.中华医院感染学杂志,2011,21(2):369-370. 〔2〕中华人民共和国卫生部医政司.全国临床检验操作规程, 〔M〕.3版.南京:东南大学出版社,2006:736-753. 〔3〕Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing , Twenty-first Informational Supplement〔S〕. 2011,M100- S21. 〔4〕吕媛,李耘,崔兰卿.2010年度卫生部全国细菌耐药监测 报告:肠杆菌科细菌耐药监测〔J〕.中华医院感染学杂志, 2011,21(24):5138-5143. 〔5〕Gootz TD,Marra A.Acinetobacter baumannii:an emerging multidrug threat〔J〕.Expert Rev Anti Infect Ther,2008,6 (3):309-325. 〔6〕周东辉,张群智.2008年大理学院附属医院肠杆菌科细菌 耐药性监测〔J〕.大理学院学报,2009,12(8):65-68. 〔7〕赵卫东,张群智.2009年附属医院产超广谱内酰胺酶大肠 埃希菌耐药性监测〔J〕.大理学院学报,2010,9(8):58- 60. 〔8〕樊笑梅,周明书,高东田.综合性医院重症监护室鲍曼不 动杆菌耐药性分析〔J〕.中国病原生物学杂志,2011,6 (11):839-841. 〔9〕梁文杰,王博,张征,等. 老年下呼吸道感染患者的病原菌 分布与耐药性分析〔J〕.中国病原生物学杂志,2012,7 (2):839-841.147-151. 〔10〕汪复.多重耐药铜绿假单胞杆菌和鲍曼不动杆菌严重感 染的防治策略〔J〕.中国感染与化疗杂志,2007,7(3): 230-232. 〔11〕Bush K. Alarming b-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae〔J〕.Curr opionion Microb,2010,13(5):558-564. 〔12〕管海宁,张群智.产茁-内酰胺酶大肠埃希菌临床检出率 及耐药性分析〔J〕.中国病原生物学杂志,2012,7(4): 299-301